You Can’t Out-MAGA Donald Trump
Why This NBC Poll on Dems and ICE Is Flat-Out Hilarious
The Liberal Media Reaction to the NYC IED Attack Was Laughably Predictable
Democrats and the Stench of Desperation
It Turns Out Democrats Once Waged War on Married Female Voters, and Guess...
This Is How What Democratic Socialists of America Really Think of Displaced Iranians...
Everyone's in on It
Intersectionality and Abandoned Leadership Is Killing the Democrats
Accountability, the New Political Buzzword
Stop the Harmful Time-Changing Ritual
Kitchen-Table Politics: Why Prescription Drug Costs Could Decide the Midterms
Man Arrested for Allegedly Stealing Veteran’s Identity and Using VA Health Care for...
Seventh U.S. Service Member Killed in Operation Epic Fury
NYPD Investigates Suspicious Device in Manhattan Vehicle After Apparent Terror Plot
NYPD Confirms Real IED Thrown at Protest Crowd
Tipsheet

The CDC Director Just Gave Us an Updated Vaccine Timeline

The CDC Director Just Gave Us an Updated Vaccine Timeline
AP Photo/Alex Brandon

We've brought you a lot of exciting vaccine news these past few weeks. And there's more of it on Tuesday. Center for Disease Control Director Robert Redfield said Americans should expect a vaccine to be rolled out very, very soon. He predicted the second week of December.

Advertisement

The next question then is, who will be receiving the first doses. He answered that too.

In an interview with Fox News anchor Dana Perino, Redfield shared that the first groups to get the vaccine will probably be "nursing home residents and then some combination of health care providers and individuals at high risk for a poor outcome."

"I do think we'll have about 40 million doses of vaccine before the end of the...year," Redfield continued. "That's enough to vaccinate 20 million people. But then it will continue through January and February and hopefully by March we'll start to see vaccine available for the general public."

Advertisement

Pfizer, who vaccine its been developing with BioNTech has produced a 95 percent efficacy rate, requested an emergency authorization from the FDA. A second vaccine candidate being produced by Moderna isn't too far behind, reporting a 94 percent effectiveness. And then a third, developed by AstraZeneca, is up to 90 percent effective.

The FDA has reportedly scheduled a meeting for Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer's request.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement